Klotho and aging

Biochimica et Biophysica Acta - General Subjects

Volumn 1790, Issue 10, 2009, Pages 1049-1058

  Kuro o, Makoto ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

FGF23; Klotho; Phosphate; Sialidase; TRPV5; Vitamin D

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; FIBROBLAST GROWTH FACTOR RECEPTOR; GLYCAN DERIVATIVE; GROWTH FACTOR; INSULIN; ION CHANNEL; KLOTHO PROTEIN; MEMBRANE PROTEIN; NITRIC OXIDE; PHOSPHATE; SIALIDASE; SOMATOMEDIN C; VANILLOID RECEPTOR 5; VITAMIN D; WNT PROTEIN;

AGING; BLOOD CHEMISTRY; BONE MINERALIZATION; CALCIFICATION; CELL PROTECTION; CELL SURFACE; COMPLEX FORMATION; DNA POLYMORPHISM; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; HEARING LOSS; HUMAN; HYPOGONADISM; LUNG EMPHYSEMA; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PHOSPHATE BALANCE; PHOSPHATE METABOLISM; PREMATURE AGING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN SECRETION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SKIN ATROPHY; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

AGING; ANIMALS; CALCIUM CHANNELS; FIBROBLAST GROWTH FACTORS; GLUCURONIDASE; HUMANS; MICE; MODELS, BIOLOGICAL; MUTATION; VITAMIN D;

MAMMALIA; MUS;

EID: 69949085836     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2009.02.005     Document Type: Review

References (114)

1. Kuro-o M., Matsumura Y., Aizawa H., et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390 (1997) 45-51
2. Kuro-o M., Hanaoka K., Hiroi Y., et al. Salt-sensitive hypertension in transgenic mice overexpressing Na(+)-proton exchanger. Circ. Res. 76 (1995) 148-153
3. Matsumura Y., Aizawa H., Shiraki-Iida T., Nagai R., Kuro-o M., and Nabeshima Y. Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem. Biophys. Res. Commun. 242 (1998) 626-630
4. Shiraki-Iida T., Aizawa H., Matsumura Y., et al. Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein. FEBS Lett. 424 (1998) 6-10
5. Mian I.S. Sequence, structural, functional, and phylogenetic analyses of three glycosidase families. Blood Cells Mol. Diseases 24 (1998) 83-100
6. Ben-Dov I.Z., Galitzer H., Lavi-Moshayoff V., et al. The parathyroid is a target organ for FGF23 in rats. J. Clin. Invest. 117 (2007) 4003-4008
7. Kamemori M., Ohyama Y., Kurabayashi M., Takahashi K., Nagai R., and Furuya N. Expression of Klotho protein in the inner ear. Hear. Res. 171 (2002) 103-110
8. Wolf I., Levanon-Cohen S., Bose S., et al. Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene 27 (2008) 7094-7105
9. Tsujikawa H., Kurotaki Y., Fujimori T., Fukuda K., and Nabeshima Y. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol. Endocrinol. 17 (2003) 2393-2403
10. Toyama R., Fujimori T., Nabeshima Y., Itoh Y., Tsuji Y., and Osamura R.Y. Impaired regulation of gonadotropins leads to the atrophy of the female reproductive system in klotho-deficient mice. Endocrinology 147 (2006) 120-129
11. Min D., Panoskaltsis-Mortari A., Kuro-o M., Hollander G.A., Blazar B.R., and Weinberg K.I. Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. Blood 109 (2007) 2529-2537
12. Yoshida T., Fujimori T., and Nabeshima Y. Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene. Endocrinology 143 (2002) 683-689
13. Kawaguchi H., Manabe N., Miyaura C., Chikuda H., Nakamura K., and Kuro-o M. Independent impairment of osteoblast and osteoclast differentiation in klotho mouse exhibiting low-turnover osteopenia. J. Clin. Invest. 104 (1999) 229-237
14. Yamashita T., Nifuji A., Furuya K., Nabeshima Y., and Noda M. Elongation of the epiphyseal trabecular bone in transgenic mice carrying a klotho gene locus mutation that leads to a syndrome resembling aging. J. Endocrinol. 159 (1998) 1-8
15. Yamashita T., Yamashita M., Noda M., and Nabeshima Y. High-resolution micro-computed tomography analyses of the abnormal trabecular bone structures in klotho gene mutant mice. J. Endocrinol. 164 (2000) 239-245
16. Suga T., Kurabayashi M., Sando Y., et al. Disruption of the klotho gene causes pulmonary emphysema in mice. Defect in maintenance of pulmonary integrity during postnatal life. Am. J. Respir. Cell Mol. Biol. 22 (2000) 26-33
17. Sato A., Hirai T., Imura A., et al. Morphological mechanism of the development of pulmonary emphysema in klotho mice. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 2361-2365
18. Nagai T., Yamada K., Kim H.C., et al. Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress. FASEB J. 17 (2003) 50-52
19. Anamizu Y., Kawaguchi H., Seichi A., et al. Klotho insufficiency causes decrease of ribosomal RNA gene transcription activity, cytoplasmic RNA and rough ER in the spinal anterior horn cells. Acta Neuropathol. (Berl) 109 (2005) 457-466
20. Lin M.T., and Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443 (2006) 787-795
21. Utsugi T., Ohno T., Ohyama Y., et al. Decreased insulin production and increased insulin sensitivity in the klotho mutant mouse, a novel animal model for human aging. Metabolism 49 (2000) 1118-1123
22. Kurosu H., Yamamoto M., Clark J.D., et al. Suppression of aging in mice by the hormone klotho. Science 309 (2005) 1829-1833
23. Brown-Borg H.M., Borg K.E., Meliska C.J., and Bartke A. Dwarf mice and the ageing process [letter]. Nature 384 (1996) 33
24. Flurkey K., Papaconstantinou J., and Harrison D.E. The Snell dwarf mutation Pit1(dw) can increase life span in mice. Mech. Ageing Dev. 123 (2002) 121-130
25. Bartke A., and Brown-Borg H. Life extension in the dwarf mouse. Curr. Top. Dev. Biol. 63 (2004) 189-225
26. Masuda H., Chikuda H., Suga T., Kawaguchi H., and Kuro-o M. Regulation of multiple ageing-like phenotypes by inducible klotho gene expression in klotho mutant mice. Mech. Ageing Dev. 126 (2005) 1274-1283
27. Duce J.A., Podvin S., Hollander W., Kipling D., Rosene D.L., and Abraham C.R. Gene profile analysis implicates Klotho as an important contributor to aging changes in brain white matter of the rhesus monkey. Glia 56 (2008) 106-117
28. Chen C.D., Podvin S., Gillespie E., Leeman S.E., and Abraham C.R. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 19796-19801
29. Imura A., Iwano A., Tohyama O., et al. Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett. 565 (2004) 143-147
30. Schiavi S.C., and Kumar R. The phosphatonin pathway: new insights in phosphate homeostasis. Kidney Int. 65 (2004) 1-14
31. Dusso A.S., Brown A.J., and Slatopolsky E. Vitamin D. Am. J. Physiol. Renal. Physiol. 289 (2005) F8-F28
32. Berndt T., and Kumar R. Phosphatonins and the regulation of phosphate homeostasis. Annu. Rev. Physiol. 69 (2007) 341-359
33. Kuro-o M. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr. Opin. Nephrol. Hypertens. 15 (2006) 437-441
34. White K.E., Evans W.E., O'Rlordan J.L.H., et al. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 26 (2000) 345-348
35. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am. J. Physiol: Endocrinol. Metab. 285 (2003) E1-E9
36. Saito H., Maeda A., Ohtomo S., et al. Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J. Biol. Chem. 280 (2005) 2543-2549
37. Liu S., Tang W., Zhou J., et al. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J. Am. Soc. Nephrol. 17 (2006) 1305-1315
38. Liu S., Gupta A., and Quarles L.D. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Curr. Opin. Nephrol. Hypertens. 16 (2007) 329-335
39. Shimada T., Kakitani M., Yamazaki Y., et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113 (2004) 561-568
40. Yu X., and White K.E. FGF23 and disorders of phosphate homeostasis. Cytokine Growth Factor Rev. 16 (2005) 221-232
41. Yu X., Ibrahimi O.A., Goetz R., et al. Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology 146 (2005) 4647-4656
42. Zhang X., Ibrahimi O.A., Olsen S.K., Umemori H., Mohammadi M., and Ornitz D.M. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J. Biol. Chem. 281 (2006) 15694-15700
43. Kurosu H., Ogawa Y., Miyoshi M., et al. Regulation of fibroblast growth factor-23 signaling by klotho. J. Biol. Chem. 281 (2006) 6120-6123
44. Urakawa I., Yamazaki Y., Shimada T., et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444 (2006) 770-774
45. Krajisnik T., Bjorklund P., Marsell R., et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J. Endocrinol. 195 (2007) 125-131
46. Shimada T., Hasegawa H., Yamazaki Y., et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J. Bone Miner. Res. 19 (2004) 429-435 Epub 2003 Dec 2029
47. Hesse M., Frohlich L.F., Zeitz U., Lanske B., and Erben R.G. Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice. Matrix Biol. 26 (2007) 75-84
48. Morishita K., Shirai A., Kubota M., et al. The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc. J. Nutr. 131 (2001) 3182-3188
49. Segawa H., Yamanaka S., Ohno Y., et al. Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice. Am. J. Physiol. Renal. Physiol. 292 (2007) F769-F779
50. Razzaque M.S., Sitara D., Taguchi T., St-Arnaud R., and Lanske B. Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J. 20 (2006) 720-722
51. Stubbs J.R., Liu S., Tang W., et al. Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J. Am. Soc. Nephrol. 18 (2007) 2116-2124
52. Medici D., Razzaque M.S., Deluca S., et al. FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis. J. Cell Biol. 182 (2008) 459-465
53. Itoh N., and Ornitz D.M. Evolution of the Fgf and Fgfr gene families. Trends Genet. 20 (2004) 563-569
54. Inagaki T., Choi M., Moschetta A., et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2 (2005) 217-225
55. Choi M., Moschetta A., Bookout A.L., et al. Identification of a hormonal basis for gallbladder filling. Nat. Med. 12 (2006) 1253-1255
56. Kharitonenkov A., Shiyanova T.L., Koester A., et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115 (2005) 1627-1635
57. Inagaki T., Dutchak P., Zhao G., et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 5 (2007) 415-425
58. Ito S., Kinoshita S., Shiraishi N., et al. Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel Klotho family protein. Mech. Dev. 98 (2000) 115-119
59. Kurosu H., Choi M., Ogawa Y., et al. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J. Biol. Chem. 282 (2007) 26687-26695
60. Ito S., Fujimori T., Furuya A., Satoh J., Nabeshima Y., and Nabeshima Y. Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho. J. Clin. Invest. 115 (2005) 2202-2208
61. Yu C., Wang F., Kan M., et al. Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J. Biol. Chem. 275 (2000) 15482-15489
62. Kurosu H., and Kuro-o M. The Klotho gene family as a regulator of endocrine fibroblast growth factors. Mol. Cell. Endocrinol. 299 (2009) 72-78
63. Kurosu H., and Kuro-o M. The Klotho gene family and the endocrine fibroblast growth factors. Curr. Opin. Nephrol. Hypertens. 17 (2008) 368-372
64. Kuro-o M. Endocrine FGFs and Klothos: emerging concepts. Trends Endocrinol. Metab. 19 (2008) 239-245
65. Tohyama O., Imura A., Iwano A., et al. Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronides. J. Biol. Chem. 279 (2004) 9777-9784
66. Cha S.K., Ortega B., Kurosu H., Rosenblatt K.P., Kuro-o M., and Huang C.L. Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 9805-9810
67. Chang Q., Hoefs S., van der Kemp A.W., Topala C.N., Bindels R.J., and Hoenderop J.G. The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 310 (2005) 490-493
68. Hoenderop J.G., Nilius B., and Bindels R.J. Calcium absorption across epithelia. Physiol. Rev. 85 (2005) 373-422
69. Imura A., Tsuji Y., Murata M., et al. alpha-Klotho as a regulator of calcium homeostasis. Science 316 (2007) 1615-1618
70. Salhanick A.I., and Amatruda J.M. Role of sialic acid in insulin action and the insulin resistance of diabetes mellitus. Am. J. Physiol. 255 (1988) E173-E179
71. Sasaki A., Hata K., Suzuki S., et al. Overexpression of plasma membrane-associated sialidase attenuates insulin signaling in transgenic mice. J. Biol. Chem. 278 (2003) 27896-27902
72. Tatar M., Bartke A., and Antebi A. The endocrine regulation of aging by insulin-like signals. Science 299 (2003) 1346-1351
73. Kenyon C. The plasticity of aging: insights from long-lived mutants. Cell 120 (2005) 449-460
74. Kenyon C., Chang J., Gensch E., Rudner A., and Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature 366 (1993) 461-464
75. Morris J.Z., Tissenbaum H.A., and Ruvkun G. A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 382 (1996) 536-539
76. Tatar M., Kopelman A., Epstein D., Tu M.-P., Yin C.-M., and Garofalo R.S. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292 (2001) 107-110
77. Clancy D.J., Gems D., Harshman L.G., et al. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292 (2001) 104-106
78. Bluher M., Kahn B.B., and Kahn C.R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299 (2003) 572-574
79. Holzenberger M., Dupont J., Ducos B., et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421 (2003) 182-187
80. Selman C., Lingard S., Choudhury A.I., et al. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB J. 22 (2008) 807-818
81. Taguchi A., Wartschow L.M., and White M.F. Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science 317 (2007) 369-372
82. Suh Y., Atzmon G., Cho M.O., et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 3438-3442
83. Ogg S., Paradis S., Gottlieb S., et al. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389 (1997) 994-999
84. Brunet A., Bonni A., Zigmond M.J., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 (1999) 857-868
85. Kops G.J., Dansen T.B., Polderman P.E., et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419 (2002) 316-321
86. Yamamoto M., Clark J.D., Pastor J.V., et al. Regulation of oxidative stress by the anti-aging hormone Klotho. J. Biol. Chem. 280 (2005) 38029-38034
87. Ikushima M., Rakugi H., Ishikawa K., et al. Anti-apoptotic and anti-senescence effects of Klotho on vascular endothelial cells. Biochem. Biophys. Res. Commun. 339 (2006) 827-832
88. Sugiura H., Yoshida T., Tsuchiya K., et al. Klotho reduces apoptosis in experimental ischaemic acute renal failure. Nephrol. Dial. Transplant. 20 (2005) 2636-2645
89. Haruna Y., Kashihara N., Satoh M., et al. Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 2331-2336
90. Saito Y., Yamagishi T., Nakamura T., et al. Klotho protein protects against endothelial dysfunction. Biochem. Biophys. Res. Commun. 248 (1998) 324-329
91. Shimada T., Takeshita Y., Murohara T., et al. Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation 110 (2004) 1148-1155
92. Saito Y., Nakamura T., Ohyama Y., et al. In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. In Process Citation. Biochem. Biophys. Res. Commun. 276 (2000) 767-772
93. Liu H., Fergusson M.M., Castilho R.M., et al. Augmented Wnt signaling in a mammalian model of accelerated aging. Science 317 (2007) 803-806
94. Scheller M., Huelsken J., Rosenbauer F., et al. Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. Nat. Immunol. 7 (2006) 1037-1047
95. Kirstetter P., Anderson K., Porse B.T., Jacobsen S.E., and Nerlov C. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat. Immunol. 7 (2006) 1048-1056
96. Kawaguchi H., Manabe N., Miyaura C., Chikuda H., Nakamura K., and Kuro-o M. Independent impairment of osteoblast and osteoclast differentiation in klotho mouse exhibiting low-turnover osteopenia. J. Clin. Invest. 104 (1999) 229-237
97. Manya H., Inomata M., Fujimori T., et al. Klotho protein deficiency leads to overactivation of mu-calpain. J. Biol. Chem. 277 (2002) 35503-35508
98. Li G., and Iyengar R. Calpain as an effector of the Gq signaling pathway for inhibition of Wnt/beta-catenin-regulated cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13254-13259
99. Essers M.A., de Vries-Smits L.M., Barker N., Polderman P.E., Burgering B.M., and Korswagen H.C. Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science 308 (2005) 1181-1184
100. Kops G.J., Medema R.H., Glassford J., et al. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol. Cell. Biol. 22 (2002) 2025-2036
101. Wolf I., Sadetzki S., Gluck I., et al. Association between diabetes mellitus and adverse characteristics of breast cancer at presentation. Eur. J. Cancer 42 (2006) 1077-1082
102. Yee D. Targeting insulin-like growth factor pathways. Br. J. Cancer 94 (2006) 465-468
103. Bartucci M., Morelli C., Mauro L., Ando S., and Surmacz E. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Cancer Res. 61 (2001) 6747-6754
104. Gery S., Tanosaki S., Bose S., Bose N., Vadgama J., and Koeffler H.P. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer. Clin. Cancer Res. 11 (2005) 3184-3190
105. Arking D.E., Krebsova A., Macek Sr. M., et al. Association of human aging with a functional variant of klotho. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 856-861
106. Arking D.E., Becker D.M., Yanek L.R., et al. KLOTHO allele status and the risk of early-onset occult coronary artery disease. Am. J. Hum. Genet. 72 (2003) 1154-1161
107. Arking D.E., Atzmon G., Arking A., Barzilai N., and Dietz H.C. Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ. Res. 96 (2005) 412-418
108. Kawano K., Ogata N., Chiano M., et al. Klotho gene polymorphisms associated with bone density of aged postmenopausal women. J. Bone Miner. Res. 17 (2002) 1744-1751
109. Ogata N., Matsumura Y., Shiraki M., et al. Association of klotho gene polymorphism with bone density and spondylosis of the lumbar spine in postmenopausal women. Bone 31 (2002) 37-42
110. Yamada Y., Ando F., Niino N., and Shimokata H. Association of polymorphisms of the androgen receptor and klotho genes with bone mineral density in Japanese women. J. Mol. Med. 83 (2005) 50-57
111. Zarrabeitia M.T., Hernandez J.L., Valero C., et al. Klotho gene polymorphism and male bone mass. Calcif. Tissue Int. 80 (2007) 10-14
112. Rhee E.J., Oh K.W., Yun E.J., et al. Relationship between polymorphisms G395A in promoter and C1818T in exon 4 of the KLOTHO gene with glucose metabolism and cardiovascular risk factors in Korean women. J. Endocrinol. Invest. 29 (2006) 613-618
113. Kachiwala S.J., Harris S.E., Wright A.F., et al. Genetic influences on oxidative stress and their association with normal cognitive ageing. Neurosci. Lett. 386 (2005) 116-120
114. Ichikawa S., Imel E.A., Kreiter M.L., et al. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J. Clin. Invest. 117 (2007) 2692-2701